Retention in buprenorphine treatment is associated with improved HCV care outcomes.
about
Chronic Hepatitis C Treatment in Patients with Drug Injection History: Findings of the INTEGRATE Prospective, Observational Study.Suboxone: Rationale, Science, Misconceptions.Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?Community-based provision of direct-acting antiviral therapy for hepatitis C: study protocol and challenges of a randomized controlled trial
P2860
Retention in buprenorphine treatment is associated with improved HCV care outcomes.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Retention in buprenorphine treatment is associated with improved HCV care outcomes.
@en
type
label
Retention in buprenorphine treatment is associated with improved HCV care outcomes.
@en
prefLabel
Retention in buprenorphine treatment is associated with improved HCV care outcomes.
@en
P2093
P2860
P1476
Retention in buprenorphine treatment is associated with improved HCV care outcomes.
@en
P2093
P2860
P356
10.1016/J.JSAT.2017.01.015
P577
2017-01-27T00:00:00Z